Skip to content

A clinical trail to study the effect of naga chendhuram in patients of back pain (lumbar spondylosis)

An open comparative clinical study on Thandaga Vatham(Lumbar Spondylosis)With the evaluation of trail drug Naga Chendhuram(Int) Moolayoga Nirkundi Thailam(Ext) and Varmam Therapy

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2017/05/008542
Enrollment
60
Registered
2017-05-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- THANDAGAVADHAM(LUMBAR SPONDYLOSIS)

Interventions

Intervention1: 1.Naga Chendhuram (int) 2.Moolayoga nirkundi thailam(Ext) : 20 patient treated with Naga chendhuram 130mg twice daily,Moolayoga nirkundi thailam external application for 48 days Interv

Sponsors

Govt Siddha Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients having any one of the symptoms of lower back pain radiates to the lower extremities anteriorly, tenderness, numbness 2.Limitation of lower back movements 3.patient willing to sign consent form

Exclusion criteria

Exclusion criteria: 1.Traumatic condition 2.Inter vertebral disc prolapse 3.Spondylolisthesis 4.Neoplasm 5.Congenital anamolies 6.Gibbus deformity 7.Sacralization 8.Cardiac diseases 9.Pregnant women and lactating mother 10.Patients with any other serious systemic illness

Design outcomes

Primary

MeasureTime frame
1.Pain reduction is evidenced by pain assessment scale (visual analogue scale). 2.Reduction of stiffness and pain present in the lumbar region. 3.Improvement in the range of movements of lumbar region. 4.Improvement in ability to sit, stand and walk for a long time without pain. Timepoint: 12months

Secondary

MeasureTime frame
Secondary outcome is assessed by comparing the safety parameters before and after treatment Timepoint: 12months

Countries

India

Contacts

Public ContactDr C R Sreedhana

govt siddha medical college

spmhibiscus@gmail.com9444190077

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026